Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1978 Feb;59(1):52–63.

Metyrapone-induced cardiovascular degenerative changes in non-arteriosclerotic and arteriosclerotic rats.

B C Wexler, B P Greenberg
PMCID: PMC2041307  PMID: 638031

Abstract

Virgin and breeder, male and female, Sprague-Dawley rats were unilaterally nephrectomized and given 1% saline drinking water. Animals were injected i.p., twice daily, with a 10 mg/100 g body wt dose of the 11-beta hydroxylation inhibitor, Metyrapone. After 7 weeks of treatment, both the previously nonarteriosclerotic virgin rats and the breeder rats with pre-existing arteriosclerosis developed de nove, widely distributed, intimal hyalinization of their peripheral arteries along with myocardial fibrosis and hyalinization of their intramyocardial coronary arteries. The Metyrapone-treated animals developed severe hypertension with greatly elevated serum creatin phosphokinase, glucose, BUN and cholesterol levels. The adrenal glands, hearts, and kidneys were greatly hypertrophied, in keeping with Metyrapone-induced extra ACTH release and the hypertension-induced myocardial and renal histopathology. Uniparous, Metyrapone-treated, female rats manifested an unusually high incidence of saccular aneurysms of the aorta. It is suggested that the hypertension and the intimal hyalinization and other specific morphologic characteristics of the cardiovascular degenerative changes observed were directly related to excess production of mineralocorticoids, e.g., deoxycorticosterone.

Full text

PDF
52

Images in this article

58Fig. 2
on p.58
58Fig. 3
on p.58
59Fig. 4
on p.59
59Fig. 5
on p.59
60Fig. 6
on p.60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carballeira A., Fishman L. M., Jacobi J. D. Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: correlation of in vivo and in vitro studies. J Clin Endocrinol Metab. 1976 Apr;42(4):687–695. doi: 10.1210/jcem-42-4-687. [DOI] [PubMed] [Google Scholar]
  2. Colby H. D., Skelton F. R., Brownie A. C. Metopirone-induced hypertension in the rat. Endocrinology. 1970 Mar;86(3):620–628. doi: 10.1210/endo-86-3-620. [DOI] [PubMed] [Google Scholar]
  3. Dingman J. F. Treatment of familial hypercholesterolemia with metyrapone. N Engl J Med. 1972 Jun 1;286(22):1214–1215. doi: 10.1056/NEJM197206012862214. [DOI] [PubMed] [Google Scholar]
  4. GUILLEMIN R., CLAYTON G. W., LIPSCOMB H. S., SMITH J. D. Fluorometric measurement of rat plasma and adrenal corticosterone concentration; a note on technical details. J Lab Clin Med. 1959 May;53(5):830–832. [PubMed] [Google Scholar]
  5. Judd J. T., Wexler B. C. The role of lactation and weaning in the pathogenesis of arteriosclerosis in female breeder rats. J Atheroscler Res. 1969 Sep-Oct;10(2):153–172. doi: 10.1016/s0368-1319(69)80004-9. [DOI] [PubMed] [Google Scholar]
  6. LARAGH J. H., CANNON P. J., AMES R. P. ALDOSTERONE SECRETION AND VARIOUS FORMS OF HYPERTENSIVE VASCULAR DISEASE. Ann Intern Med. 1963 Jul;59:117–120. doi: 10.7326/0003-4819-59-1-117. [DOI] [PubMed] [Google Scholar]
  7. LIDDLE G. W., ISLAND D., LANCE E. M., HARRIS A. P. Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 beta-hydroxylation. J Clin Endocrinol Metab. 1958 Aug;18(8):906–912. doi: 10.1210/jcem-18-8-906. [DOI] [PubMed] [Google Scholar]
  8. Melby J. C., Dale S. L., Grekin R. J., Gaunt R., Wilson T. E. 18-Hydroxy-11-deoxycorticosterone (18-OH-DOC) secretion in experimental and human hypertension. Recent Prog Horm Res. 1972;28:287–351. [PubMed] [Google Scholar]
  9. Nilsson K. O., Hökfelt B. Influence of metyrapone on plasma concentrations of testosterone and androstenedione in man. Acta Endocrinol (Copenh) 1971 Nov;68(3):576–584. doi: 10.1530/acta.0.0680576. [DOI] [PubMed] [Google Scholar]
  10. Suzuki Y. Sex difference in hypertensive action of metopirone in relation to its plasma levels in the rat. Endocrinology. 1972 Apr;90(4):924–930. doi: 10.1210/endo-90-4-924. [DOI] [PubMed] [Google Scholar]
  11. WEXLER B. C., KITTINGER G. W. ADRENOCORTICAL FUNCTION IN ARTERIOSCLEROTIC FEMALE BREEDER RATS. J Atheroscler Res. 1965 May-Jun;5(3):317–329. doi: 10.1016/s0368-1319(65)80047-3. [DOI] [PubMed] [Google Scholar]
  12. WEXLER B. C. SPONTANEOUS ARTERIOSCLEROSIS IN REPEATEDLY BRED MALE AND FEMALE RATS. J Atheroscler Res. 1964 Jan-Feb;4:57–80. doi: 10.1016/s0368-1319(64)80016-8. [DOI] [PubMed] [Google Scholar]
  13. WEXLER B. C. SPONTANEOUS CORONARY ARTERIOSCLEROSIS IN REPEATEDLY BRED MALE AND FEMALE RATS. Circ Res. 1964 Jan;14:32–43. doi: 10.1161/01.res.14.1.32. [DOI] [PubMed] [Google Scholar]
  14. WEXLER B. C., TRUE C. W. Carotid and cerebral arteriosclerosis in the rat. Circ Res. 1963 Jun;12:659–666. doi: 10.1161/01.res.12.6.659. [DOI] [PubMed] [Google Scholar]
  15. Wexler B. C. Arteriosclerosis of the renal artery in repeatedly bred male and female rats. Atherosclerosis. 1970 May-Jun;11(3):383–400. doi: 10.1016/0021-9150(70)90018-3. [DOI] [PubMed] [Google Scholar]
  16. Wexler B. C., Lutmer R. F. ACTH content of pituitary glands of arteriosclerotic breeder vs. non-arteriosclerotic virgin rats. Atherosclerosis. 1975 Sep-Oct;22(2):199–214. doi: 10.1016/0021-9150(75)90003-9. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES